When is adjusting preventative treatment strongly indicated for an asthma patient?

Using a reliever inhaler more than twice a week

Medical guidelines establish clear metrics for assessing the adequacy of current preventative asthma control. If a patient finds themselves needing to use their short-acting reliever (or quick-relief) inhaler more frequently than twice within a seven-day period, it signifies that the underlying inflammation is not being sufficiently managed by their current controller regimen. Furthermore, experiencing regular awakenings during the night due to asthma symptoms is another critical indicator that the preventative therapy needs modification or initiation. Relying solely on a short-acting reliever leaves the core inflammatory process untreated, which is contrary to recommended best practices for asthma management.